Overview

In the months leading up to the Fall 2008 Health 2.0 Conference, the Accelerator facilitated its first collaboration: the Drug Profile Interoperability (“DPI”) project. Because of the DPI project, users of DestinationRx’s Medicine Cabinet or PharmaSURVEYOR’s web application can now access a valuable combination of drug safety and cost information that is not otherwise available from any single company.

The project's contribution back to the community:

Lightweight Open Framework Leavebehind Document Phase 1, v1

What's Happening Now?

Pursuing Distribution
PharmaSURVEYOR is exploring a partnership with Polka to enable users of Polka’s iPhone application to enter medications and leverage PharmaSURVEYOR’s analytics.

Exploring Evolution
H2A is now working with PharmaSURVEYOR to explore approaches for making a service that combines safety and other types of medication-related analyses available to other H2A members while enabling a pay-for-use model.

Are you interested in working with members of the DPI Project or proposing a New Project of your own?

Contact H2A to learn about DPI Opportunities

Propose a New Project

Problem

Decision support to aid drug selection currently addresses pricing, safety and effectiveness as separate concerns, preventing the user from understanding the big picture and making wise trade-offs.

Proposed solution

Support interoperation between currently separate solutions by providing links between the sites and moving consumer patient data between sites with appropriate privacy and security authorizations. In the process of providing this solution the project participants also aim to make it technically possible for third parties to utilize the participant's web services, i.e., for other organizations and vendors to be sent data from DestinationRx for processing, and to send data to PharmaSURVEYOR for processing. The initial delivery will support secure unidirectional movement of data between two interoperating sites/services; a secondary release aims to support bi-directional sharing of data.

Framework to be contributed back to the Accelerator

We will develop a light-weight, interoperation framework starting with the designation of appropriate standards and technologies (domain-specific as well as horizontal) along with tightly focused guidelines for their application and use (naming conventions, namespaces, process flow, UI information architecture conventions). All non-proprietary aspects of the framework, as outlined below, will be returned to the Accelerator.

Sector impact

Consumers, providers, physicians, pharmacists and payers may evaluate current and prospective drug regimen treatments on cost and safety concerns.

Ultimate consumer impact

A DestinationRx user is provided a button or link that when clicked generates and displays a PharmaSURVEYOR Regimen Survey of the user's DRx Medicine Cabinet drugs. The consumer can also play "what-if" to see the impact of adding, replacing, and removing drugs on their risks of adverse drug effects.

Project members

Lightweight Open Framework Leavebehind Document Phase 1, v1